Literature DB >> 7210373

Transperineal percutaneous I-125 implant of prostate.

P P Kumar, F F Bartone.   

Abstract

Although Iodine-125 seeds for interstitial radiation of prostatic cancer via the retropubic route is an established method of treatment, the retropubic implant technique has disadvantages: inadequate space for proper placement of the needles, possible bleeding from the prostatic venous plexus by the insertion of needles through these veins, and possible wound infection due to inadvertent puncturing of the bladder and/or rectum by the needles. A technique is described whereby Iodine-125 seeds for interstitial radiation are placed into the prostate through the perineum allowing more accurate placement of the seeds, assuring homogenous dose distribution, and decreasing the risk of bleeding and of bacterial contamination.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7210373     DOI: 10.1016/0090-4295(81)90037-6

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Iodine 125 interstitial irradiation for localized prostate cancer.

Authors:  P P Kumar; R R Good; F F Bartone
Journal:  J Natl Med Assoc       Date:  1990-03       Impact factor: 1.798

2.  "C" arm guidance in interstitial brachytherapy of pelvic malignancies.

Authors:  P P Kumar; F F Bartone; A J Jacobs; J E Taylor; E O Jones
Journal:  J Natl Med Assoc       Date:  1983-11       Impact factor: 1.798

3.  Computerized tomography: its role in interstitial brachytherapy of pelvic malignancies.

Authors:  P P Kumar; J Taylor; E O Jones; B McAnulty
Journal:  J Natl Med Assoc       Date:  1986-02       Impact factor: 1.798

4.  Prostate brachytherapy: HDR or seed implant.

Authors:  K R Das
Journal:  J Med Phys       Date:  2006-10

5.  Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost.

Authors:  Anurag K Singh; Peter Guion; Robert C Susil; Deborah E Citrin; Holly Ning; Robert W Miller; Karen Ullman; Sharon Smith; Nancy Sears Crouse; Denise J Godette; Bronwyn R Stall; C Norman Coleman; Kevin Camphausen; Cynthia Ménard
Journal:  Radiat Oncol       Date:  2006-08-16       Impact factor: 3.481

6.  Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy.

Authors:  Joshua Moorrees; John M Lawson; Loredana G Marcu
Journal:  Radiat Oncol       Date:  2012-11-22       Impact factor: 3.481

Review 7.  Brachytherapy: update and results.

Authors:  Rodney J Ellis; Edward Kim
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.